Oral anticoagulation in Atrial Fibrillation with CHA2DS2-VASc = 1: too much uncertainty?
Fernando Botto – Patients with any form of Atrial Fibrillation (AF) having an estimated thromboembolic risk (stroke or systemic embolism) of 1% or more per year should be considered for … Continue reading Oral anticoagulation in Atrial Fibrillation with CHA2DS2-VASc = 1: too much uncertainty?
CARDiOmics Club 